- abnormal locomotor behavior / IMPC
- hyperactivity / IMPC
- abnormal gait / IMPC
- decreased exploration in new environment / IMPC
- increased circulating serum albumin level / IMPC
- hypoalgesia / IMPC
- increased blood urea nitrogen level / IMPC
- increased circulating iron level / IMPC
- decreased prepulse inhibition / IMPC
- impaired contextual conditioning behavior / IMPC
- impaired cued conditioning behavior / IMPC
- abnormal freezing behavior / IMPC
- decreased freezing behavior / IMPC
- increased mechanical nociceptive threshold / IMPC
C57BL/6NTac-Gria1em1(IMPC)H/H
Status | Available to order |
EMMA ID | EM:12371 |
International strain name | C57BL/6NTac-Gria1em1(IMPC)H/H |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Gria1em1(IMPC)H |
Gene/Transgene symbol | Gria1 |
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- hyperactivity / IMPC
- increased circulating amylase level / IMPC
- decreased freezing behavior / IMPC
- decreased exploration in new environment / IMPC
- increased circulating serum albumin level / IMPC
- decreased prepulse inhibition / IMPC
- increased blood urea nitrogen level / IMPC
- impaired contextual conditioning behavior / IMPC
- increased circulating alkaline phosphatase level / IMPC
- abnormal freezing behavior / IMPC
- abnormal gait / IMPC
- impaired cued conditioning behavior / IMPC
- increased circulating iron level / IMPC
- increased mechanical nociceptive threshold / IMPC
- abnormal locomotor behavior / IMPC
- decreased bone mineral content / IMPC
- decreased vertical activity / IMPC
- hypoalgesia / IMPC
- decreased startle reflex / IMPC
MGI phenotypes (gene matching)
- abnormal spinal cord morphology / MGI
- decreased body size / MGI
- abnormal social investigation / MGI
- increased anxiety-related response / MGI
- decreased anxiety-related response / MGI
- abnormal locomotor behavior / MGI
- hyperactivity / MGI
- abnormal response to new environment / MGI
- increased exploration in new environment / MGI
- reduced long term potentiation / MGI
- absent long term depression / MGI
- impaired synaptic plasticity / MGI
- abnormal associative learning / MGI
- no abnormal phenotype detected / MGI
- abnormal long term potentiation / MGI
- abnormal sexual interaction / MGI
- abnormal emotion/affect behavior / MGI
- increased vertical activity / MGI
- abnormal nociception after inflammation / MGI
- no phenotypic analysis / MGI
- nervous system phenotype / MGI
- decreased aggression towards males / MGI
- abnormal serotonin level / MGI
- homeostasis/metabolism phenotype / MGI
- behavior/neurological phenotype / MGI
- increased blood urea nitrogen level / MGI
- decreased glycosylated hemoglobin level / MGI
- abnormal dendrite morphology / MGI
- abnormal long term spatial reference memory / MGI
- decreased chemical nociceptive threshold / MGI
- induced hyperactivity / MGI
- abnormal behavioral response to xenobiotic / MGI
- decreased behavioral withdrawal response / MGI
- reduced AMPA-mediated synaptic currents / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).